- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT01689948
Alzheimer Disease : Rehabilitation's Intervention at Home (pré MATAPA)
Alzheimer Disease : Rehabilitation's Intervention at Home. A Preliminary Pilot Study.
Alzheimer's disease (AD) is the most common cause of dementia among elderly patients. By its prevalence and its medical and social consequences, AD represents a dual challenge to public health and society. The elderly want to stay in their homes even when their lives are altered by a chronic progressive disease. Their caregivers claim in turn a support at home. But this desire is questioned because of the characteristics of the disease, e.g. the altered relational function by the cognitive impairment and the behavioural disorders associated.
Outpatients non-drug therapies represent a potential support that adapts to patient with an AD or mixed dementia, especially in their milder forms.
The aim of the study is to evaluate the feasibility of a weekly rehabilitation's intervention at home and its acceptability by both the patient and the caregiver.
The study of its efficiency in terms of autonomy will be the next step.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The protocol is based on weekly rehabilitation's intervention at home. All home visits and assessments of the patient and his caregiver will be made by the rehabilitation's therapist himself.
Twelve weekly interventions at home are planed. The first five are needed to define a realistic and achievable goal of treatment which is accepted by the dyad and the therapist. The following seven interventions will achieve this goal by rehabilitation's intervention (e.g. occupational therapy, psychomotor approach).
Four filmed sessions for dyad's assessment are planned (at inclusion, at weeks 5 and 12 after inclusion and 3 months after the last intervention).
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Nantes, França, 44093
- Bellier Hospital, CHU of Nantes
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Patient's inclusion criteria:
- Aged 65 and over
- AD or mixed dementia (DSM IV TR criteria), documented by a neuropsychological assessment and a brain imaging
- Living at home
- Having a caregiver (more than 2 visits per week)
- Agreement for the study
Caregiver's inclusion criteria :
- More than 2 patient's visits per week
- Agreement for the study
Patient's exclusion criteria:
- Life expectancy less than 1 year
- Guardianship
- Already having a rehabilitation program's therapy
- Participation in a pharmacological study
Caregiver's exclusion criteria:
- Medical condition requiring regular care
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Home rehabilitation therapy
12 weekly sessions of Home rehabilitation therapy
|
12 sessions of home rehabilitation therapy
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)
Prazo: 27 weeks
|
The main objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)
Prazo: 5 weeks
|
This objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 5 weeks later (meaning after the fifth weekly session of at home rehabilitation therapy).
|
5 weeks
|
Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)
Prazo: 13 weeks
|
This objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 13 weeks later (meaning after the twelfth weekly session of at home rehabilitation therapy).
|
13 weeks
|
Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)
Prazo: 27 weeks
|
This objective is to compare the mean scores of Neuro Psychiatric Inventory(NPI) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)
Prazo: 5 weeks
|
This objective is to compare the mean scores of Neuro Psychiatric Inventory(NPI) observed at inclusion (day 0) with those observed 5 weeks later (meaning after the last of the fifth weekly session of at home rehabilitation therapy).
|
5 weeks
|
Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)
Prazo: 13 weeks
|
This objective is to compare the mean scores of Neuro Psychiatric Inventory(NPI) observed at inclusion (day 0) with those observed 12 weeks later (meaning after the last of the twelfth weekly session of at home rehabilitation therapy).
|
13 weeks
|
Evaluation of the mean scores of Zarit's scale (caregiver burden)
Prazo: 13 weeks
|
This objective is to compare the mean scores of Zarit's scale observed at inclusion (day 0) with those observed 13 weeks later (meaning after the twelfth weekly session of at home rehabilitation therapy).
|
13 weeks
|
Evaluation of the mean scores of Zarit's scale (caregiver burden)
Prazo: 27 weeks
|
This objective is to compare the mean scores of Zarit's scale observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Zarit's scale (caregiver burden)
Prazo: 5 weeks
|
This objective is to compare the mean scores of Zarit's scale observed at inclusion (day 0) with those observed 5 weeks later (meaning after the last of the fifth weekly session of at home rehabilitation therapy).
|
5 weeks
|
Alcohol consumption for the patient and the caregiver
Prazo: 27 weeks
|
This objective is to compare the alcohol consumption for the patient and the caregiver observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Mini Mental State Examination (MMSE)(meaning evaluation of patient's cognitive impairment)
Prazo: 27 weeks
|
This objective is to compare the mean scores of Mini Mental State Examination (MMSE) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Evaluation of the mean scores of Goal Attainment scales (GAS) (meaning evaluation of the satisfaction of the patient and of her/his caregiver)
Prazo: 27 weeks
|
This objective is to compare the mean scores of Goal Attainment Scales (GAS) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).
|
27 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Gilles Berrut, Pr, Bellier Hospital, CHU of Nantes
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- RC12_0080
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Home rehabilitation therapy
-
University Hospital, LinkoepingLinkoeping University; Ryhov County HospitalDesconhecido
-
Pamukkale UniversityConcluído
-
University of PennsylvaniaRescindidoInfecção Recorrente por Clostridium DifficileEstados Unidos
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; McClay Foundation; The Leo and Peggy Pierce Family...Recrutamento
-
Axem Neurotechnology Inc.Massachusetts General HospitalRecrutamento
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA); Visiting Nurse Service of New YorkConcluído
-
Azienda Ospedaliera Universitaria Integrata VeronaConcluído
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA); Visiting Nurse Service of New YorkRecrutamento
-
University of MichiganConcluídoSintomas Comportamentais | Desordem depressiva | Depressão | Transtornos de Humor | Distúrbio mentalEstados Unidos